Company Monitoring Page for Amgen

latest headlines for company on cafepharma

Amgen launches Humira biosimilar, releases Q4 earnings report
Medical Marketing and Media
Tue, 01/31/23 - 11:21 pm
Tags:
Amgen, Humira, biosimilars, earnings, AbbVie, Amjevita
Humira biosimilars arrive in the US, as Amgen launches first copycat to AbbVie’s blockbuster drug
BioPharma Dive
Tue, 01/31/23 - 12:37 pm
Tags:
AbbVie, Humira, biosimilars, Amgen
Amgen commits $8m to improve clinical trial diversity
Outsourcing Pharma
Tue, 01/31/23 - 10:24 am
Tags:
Amgen, clinical trials, clinical trial diversity, Bristol Myers Squibb, Winn Award
Amgen, navigating 'industry headwinds,' puts 300 commercial jobs on chopping block
Fierce Pharma
Mon, 01/30/23 - 10:54 am
Tags:
Amgen, layoffs
Warren keeps pressure on pharma, this time targeting Amgen and Indivior buyouts
Fierce Pharma
Mon, 01/30/23 - 10:41 am
Tags:
Elizabeth Warren, Senate, FTC, M&A, Amgen, Horizon Therapeutics, Indivior, Opiant Pharmaceuticals
Amgen extends autoimmune pact with small Michigan biotech
Endpoints
Wed, 01/18/23 - 11:02 pm
Tags:
Amgen, autoimmune disease, Evoq Therapeutics
Amgen prepped to take first slice of AbbVie’s US Humira pie
BioProcess International
Wed, 01/18/23 - 11:00 pm
Tags:
Amgen, Humira, biosimilars, adalimumab, Amjevita
NewAmsterdam's Amgen castoff cuts LDL cholesterol in phase 2, opening new front in race to market
Fierce Biotech
Tue, 01/17/23 - 10:32 am
Tags:
NewAmsterdam Pharma, Amgen, CETP inhibitors, obicetrapib, clinical trials
Big caps bounce back for biopharma
EP Vantage
Mon, 01/16/23 - 11:14 am
Tags:
pharma stocks, Amgen, BeiGene, Bristol Myers Squibb, Gilead Sciences, Lantheus Holdings, Madrigal Pharmaceuticals, Merck, Moderna Therapeutics, Novo Nordisk, Prometheus Biosciences, Roche
Biopharma’s bolt-on bonanza is set to continue
EP Vantage
Thu, 01/12/23 - 10:18 am
Tags:
M&A, Amgen, AstraZeneca, Bristol Myers Squibb, GSK, Ipsen, Merck, Pfizer
Amgen Boasts Lucrative Acquisitions, Drug Updates, Burgeoning Biosimilars at JPM
BioSpace
Tue, 01/10/23 - 06:43 pm
Tags:
Amgen, JPMHC 2023, M&A, biosimilars
Amgen piles $2B more into pharma's ADC rush in Synaffix pact
Fierce Biotech
Thu, 01/5/23 - 04:42 pm
Tags:
Amgen, antibody-drug conjugate, Synaffix
Amgen files brief to Supreme Court ahead of oral arguments — with industry amicus support
Endpoints
Tue, 01/3/23 - 10:24 pm
Tags:
Amgen, Sanofi, Regeneron, Supreme Court, legal, innovation, patents, Repatha, Praluent
ADC deals: Mersana engages with Merck, LegoChem and Amgen collaborate
Biopharma Reporter
Mon, 01/2/23 - 06:41 pm
Tags:
antibody-drug conjugate, Merck, LegoChem Biosciences, Mersana, Amgen, GSK, Janssen
Billionaire John Paulson Stands To Make $500 Million From Horizon’s Sale To Amgen
Forbes
Wed, 12/14/22 - 07:22 pm
Tags:
Amgen, M&A, Horizon Therapeutics, John Paulson
Biopharma’s 5 Biggest M&A Deals of 2022
BioSpace
Wed, 12/14/22 - 10:50 am
Tags:
M&A, Amgen, Horizon Therapeutics, Pfizer, Biohaven, Global Blood Therapeutics, Bristol Myers Squibb, Turning Point Therapeutics, ChemoCentryx
FDA Approval of Mirati Lung Cancer Drug Sets Stage for Competition With Amgen
MedCity News
Wed, 12/14/22 - 10:19 am
Tags:
Amgen, Mirati Therapeutics, Krazati, Lumakras, FDA, lung cancer
Amgen to Buy Horizon in Biotech’s Biggest Deal of 2022
BioSpace
Mon, 12/12/22 - 10:34 am
Tags:
Amgen, Horizon Therapeutics, M&A
Could Amgen's Heart Disease Candidate Generate Billions in Sales?
Motley Fool
Sun, 12/11/22 - 01:26 pm
Tags:
Amgen, heart disease, olpasiran
Senate Finance chair goes after Amgen again on US taxes, asking for payment specifics
Endpoints
Thu, 12/8/22 - 11:25 pm
Tags:
Senate, taxes, Amgen

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.